The abrupt closure of three LOOK Dine-In Cinemas in the Los Angeles area highlights the mounting pressures on mid-sized theater chains, caught between streaming dominance, costly upgrades, and shifting audience habits.
As reproductive rights face escalating legal threats, personal finance experts are advising clients to prioritize dedicated savings for abortion access—a stark reflection of America's shifting healthcare landscape.
French biotech ABIVAX reports positive Phase 3 results for its lead drug obefazimod in ulcerative colitis, meeting key secondary endpoints with a clean safety profile. With funding secured through late 2027, the company plans to advance pivotal maintenance and Crohn's disease trials, reshaping its investment narrative.
For retirees, neglecting to rebalance an investment portfolio is no longer a minor oversight—it's a critical risk that can amplify losses, deplete reserves, and permanently alter a retirement's trajectory. Behavioral biases and market momentum often conspire to create a dangerous imbalance between stocks and bonds, leaving savers exposed just when protection matters most.
Elon Musk consolidates his space and AI ventures, positioning SpaceX's Starship rocket as the cornerstone for an ambitious vision of space-based computing infrastructure.
A new WalletHub analysis of 182 U.S. cities places Detroit among the lowest for household budgeting skills, highlighting stark contrasts in spending, credit, and savings behaviors across the nation.
A sharp reversal in institutional ETF flows, weakening U.S. demand, and tightening market liquidity are signaling a potential regime shift for Bitcoin, with analysts warning of further downside risk.
Monolithic Power Systems (MPWR) is capitalizing on surging demand from AI data centers and the automotive sector, with both segments now forming a larger part of its revenue mix. The company is also rewarding shareholders through significant buybacks and a dividend hike, signaling confidence in its financial health and growth trajectory.
Buoyed by record orders and a surging backlog, Johnson Controls International plc kicks off fiscal 2026 with robust growth, margin expansion, and heightened confidence, driven largely by its pivotal role in cooling the AI revolution.
As investors look beyond the index's recent strong run, a century-old pattern linked to U.S. midterm elections points to potential volatility ahead—and possible gains thereafter.
In a Morning Joe appearance, FT columnist Ed Luce cited newly released documents suggesting Jeffrey Epstein's network had 'deep coordination' with Russian officials, highlighting a 2016 meeting with a former Russian ambassador and Peter Thiel.
With AI chip power demands soaring, Vertiv Holdings Co's advanced cooling solutions are emerging as a critical bottleneck—and a strategic investment. Its deep partnership with Nvidia provides a key competitive edge in a market where reliability trumps cost.
Paychex solidifies its position in the competitive human capital management sector by finalizing its acquisition of Paycor and launching an integrated Bill Pay service, aiming to create a more comprehensive suite for small and mid-sized businesses.
U.N. Secretary-General Antonio Guterres has issued his starkest warning yet, stating the organization faces an imminent cash crisis due to unpaid member fees, primarily from the United States, and an internal budget rule forcing the return of unspent funds.
Amgen pushes back against regulators seeking to pull a key drug, while Pfizer faces investor skepticism over its obesity candidate. Meanwhile, Merck details an ambitious plan to offset the looming patent cliff of its blockbuster Keytruda and reach $70 billion in annual sales.
As major indices rally on strong economic data, savvy investors are turning their attention to lesser-known companies with solid fundamentals. We analyze three small-cap stocks that combine financial resilience with attractive valuations in the current climate.
Shares of Pharming Group (ENXTAM:PHARM) came under pressure after the U.S. FDA issued a Complete Response Letter for its supplemental filing of Joenja in children with APDS. While the short-term sentiment turned negative, the company's longer-term growth trajectory and valuation gap present a complex picture for investors.
LiveRamp Holdings' shares have tumbled nearly 70% over five years, presenting a stark contrast between its discounted cash flow valuation and its premium trading multiples. As the market grapples with its positioning, investors are left weighing deep-seated pessimism against potential hidden value.
Elon Musk's move to merge his AI startup xAI into SpaceX ahead of a blockbuster IPO has ignited debate. While supporters see a visionary bet on orbital data centers and AI supremacy, critics decry it as financial engineering that leverages one company to prop up another.
The future of Eddie Bauer's brick-and-mortar presence across North America is in question as its operator, Catalyst Brands, prepares for a potential Chapter 11 bankruptcy filing, raising concerns for stores from Southern California to New Jersey.
